ABSTRACT
Pompe disease (PD) is a monogenic autosomal recessive disorder caused by biallelic pathogenic variants of the GAA gene encoding lysosomal alpha-glucosidase; its loss causes glycogen storage in lysosomes, mainly in the muscular tissue. The genotype-phenotype correlation has been extensively discussed, and caution is recommended when interpreting the clinical significance of any mutation in a single patient. As there is no evidence that environmental factors can modulate the phenotype, the observed clinical variability in PD suggests that genetic variants other than pathogenic GAA mutations influence the mechanisms of muscle damage/repair and the overall clinical picture. Genes encoding proteins involved in glycogen synthesis and catabolism may represent excellent candidates as phenotypic modifiers of PD. The genes analyzed for glycogen synthesis included UGP2, glycogenin (GYG1-muscle, GYG2, and other tissues), glycogen synthase (GYS1-muscle and GYS2-liver), GBE1, EPM2A, NHLRC1, GSK3A, and GSK3B. The only enzyme involved in glycogen catabolism in lysosomes is α-glucosidase, which is encoded by GAA, while two cytoplasmic enzymes, phosphorylase (PYGB-brain, PGL-liver, and PYGM-muscle) and glycogen debranching (AGL) are needed to obtain glucose 1-phosphate or free glucose. Here, we report the potentially relevant variants in genes related to glycogen synthesis and catabolism, identified by whole exome sequencing in a group of 30 patients with late-onset Pompe disease (LOPD). In our exploratory analysis, we observed a reduced number of variants in the genes expressed in muscles versus the genes expressed in other tissues, but we did not find a single variant that strongly affected the phenotype. From our work, it also appears that the current clinical scores used in LOPD do not describe muscle impairment with enough qualitative/quantitative details to correlate it with genes that, even with a slightly reduced function due to genetic variants, impact the phenotype.
ABSTRACT
Increasing evidence has shown that DNA methylation is involved in gene regulation in prokaryotes. However, there have been very limited reports about the role of DNA methylation in regulation of gene expression and physiological functions in cyanobacteria. In Synechocystis sp. PCC 6803, four genes on the plasmid pSYSX are predicted to encode the type I restriction-methylation system, slr6095 and slr6096 for the M subunit, slr6097 for the S subunit and slr6102 for the R subunit. Compared to the wild type, slr6095, slr6096, and slr6097 mutants lacked the GGm6AN7TTGG/CCAm6AN7TCC methylation in genomic DNA. Transcriptomic analysis indicated that 171 genes were reproducibly up- or down-regulated in all three mutants relative to the wild type. The changed expression of some genes, including sll1356 for glycogen phosphorylase (GlgP), was associated with the loss of GGm6AN7TTGG/CCAm6AN7TCC methylation in the coding regions or the upstream non-coding sequences. Inactivation of slr6095, slr6096, or slr6097 increased the expression of sll1356 and the GlgP activity but lowered the glycogen content. These results indicated that the DNA methylation by a type I RM system could alter the expression of certain genes and physiological functions in Synechocystis sp. PCC 6803.
ABSTRACT
BACKGROUND: A substrate cycle is a metabolic transformation in which a substrate A is phosphorylated to A-P at the expense of ATP (or another "high energy" compound), and A-P is converted back to A by a nucleotidase or a phosphatase. Many biochemists resisted the idea of such an ATP waste. Why a non-phosphorylated metabolite should be converted into a phosphorylated form, and converted back to its non-phosphorylated form through a "futile cycle"? AIM OF REVIEW: In this Review we aim at presenting our present knowledge on the biochemical features underlying the interrelation between the muscle purine nucleotide cycle and the oxypurine cycle, and on the metabolic responses of the two cycles to increasing intensities of muscle contraction. KEY SCIENTIFIC CONCEPTS OF REVIEW: Nowadays it is widely accepted that the substrate cycles regulate many vital functions depending on the expense of large amounts of ATP, including skeletal muscle contraction, so that the expense of some extra ATP and "high energy" compounds, such as GTP and PRPP via substrate cycles, is not surprising. The Review emphasizes the strict metabolic interrelationship between the purine nucleotide cycle and the oxipurine cycle.
Subject(s)
Metabolomics , Muscle Contraction , Muscle, Skeletal/metabolism , Purines/chemistry , Purines/metabolism , HumansABSTRACT
Cyanobacteria acclimatize to nitrogen deprivation by changing cellular metabolism. The nitrogen-regulated response regulator A (NrrA) is involved in regulation of carbon metabolism in response to nitrogen deprivation. However, it has not been elucidated whether these regulatory functions of NrrA are particular to a few model strains or are general among diverse cyanobacteria. In this study, we showed that regulation and functions of NrrA were highly conserved among ß-cyanobacteria, which included physiologically and ecologically diverse strains. All ß-cyanobacteria had the nrrA gene, while it was absent in α-cyanobacteria. The canonical NtcA-dependent promoter sequence was found upstream of the nrrA genes in most ß-cyanobacteria, and its expression was indeed induced by nitrogen deprivation. Biochemical and physiological analyses of NrrA from phylogenetically distinct cyanobacteria indicated that regulation of NrrA activity and NrrA functions, namely activation of glycogen catabolism, were also common to ß-cyanobacteria. These results support the conclusion that NrrA plays an important role in acclimatization to nitrogen deprivation, and that activation of glycogen catabolism is a primitive response to nitrogen deprivation in ß-cyanobacteria.